CN111264813A - Multifunctional konjac flour and preparation method thereof - Google Patents
Multifunctional konjac flour and preparation method thereof Download PDFInfo
- Publication number
- CN111264813A CN111264813A CN202010212555.8A CN202010212555A CN111264813A CN 111264813 A CN111264813 A CN 111264813A CN 202010212555 A CN202010212555 A CN 202010212555A CN 111264813 A CN111264813 A CN 111264813A
- Authority
- CN
- China
- Prior art keywords
- konjac
- multifunctional
- group
- konjac flour
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920002752 Konjac Polymers 0.000 title claims abstract description 84
- 235000010485 konjac Nutrition 0.000 title claims abstract description 82
- 241001312219 Amorphophallus konjac Species 0.000 title claims abstract description 67
- 235000001206 Amorphophallus rivieri Nutrition 0.000 title claims abstract description 67
- 239000000252 konjac Substances 0.000 title claims abstract description 67
- 235000013312 flour Nutrition 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 239000000843 powder Substances 0.000 claims abstract description 48
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 32
- 238000000926 separation method Methods 0.000 claims abstract description 18
- 239000007788 liquid Substances 0.000 claims abstract description 17
- 108090000790 Enzymes Proteins 0.000 claims abstract description 14
- 102000004190 Enzymes Human genes 0.000 claims abstract description 14
- 238000002156 mixing Methods 0.000 claims abstract description 11
- 238000001694 spray drying Methods 0.000 claims abstract description 8
- 238000000967 suction filtration Methods 0.000 claims abstract description 8
- 108010059892 Cellulase Proteins 0.000 claims description 15
- 229940106157 cellulase Drugs 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 14
- 108010059820 Polygalacturonase Proteins 0.000 claims description 13
- 238000001035 drying Methods 0.000 claims description 13
- 229940088598 enzyme Drugs 0.000 claims description 13
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 13
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 238000005119 centrifugation Methods 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 25
- 210000004369 blood Anatomy 0.000 abstract description 25
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 10
- 235000013305 food Nutrition 0.000 abstract description 5
- 201000001421 hyperglycemia Diseases 0.000 abstract description 3
- 235000016709 nutrition Nutrition 0.000 abstract description 3
- 238000012545 processing Methods 0.000 abstract description 3
- 241000700159 Rattus Species 0.000 description 26
- 241000699670 Mus sp. Species 0.000 description 14
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 13
- 239000008103 glucose Substances 0.000 description 13
- 229920001542 oligosaccharide Polymers 0.000 description 11
- 150000002482 oligosaccharides Chemical class 0.000 description 11
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 9
- 229920002581 Glucomannan Polymers 0.000 description 9
- 229940046240 glucomannan Drugs 0.000 description 9
- 150000004676 glycans Chemical class 0.000 description 9
- 229920001282 polysaccharide Polymers 0.000 description 9
- 239000005017 polysaccharide Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 238000003304 gavage Methods 0.000 description 8
- 230000015556 catabolic process Effects 0.000 description 7
- 238000006731 degradation reaction Methods 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 239000003814 drug Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 208000008589 Obesity Diseases 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 235000021050 feed intake Nutrition 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 235000020824 obesity Nutrition 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000007619 statistical method Methods 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 238000005034 decoration Methods 0.000 description 2
- 238000000556 factor analysis Methods 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 230000007760 free radical scavenging Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000007928 intraperitoneal injection Substances 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 210000004003 subcutaneous fat Anatomy 0.000 description 2
- XPFJYKARVSSRHE-UHFFFAOYSA-K trisodium;2-hydroxypropane-1,2,3-tricarboxylate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].[Na+].OC(=O)CC(O)(C(O)=O)CC(O)=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O XPFJYKARVSSRHE-UHFFFAOYSA-K 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- AEMOLEFTQBMNLQ-YMDCURPLSA-N D-galactopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-YMDCURPLSA-N 0.000 description 1
- 206010013183 Dislocation of vertebra Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 239000006057 Non-nutritive feed additive Substances 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 235000021316 daily nutritional intake Nutrition 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 1
- 229960003105 metformin Drugs 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 238000010525 oxidative degradation reaction Methods 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 210000005084 renal tissue Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
- A23L19/115—Konjak; Konntaku
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention provides multifunctional konjac flour and a preparation method thereof, and belongs to the field of nutritional food processing. Mixing konjak fine powder, enzyme and water, and carrying out enzymolysis to obtain an zymolyte; then sequentially carrying out centrifugal separation and suction filtration on the zymolyte to obtain a liquid part; and spray drying the obtained liquid part to finally obtain the multifunctional konjac flour which has the functions of reducing blood fat and blood sugar and improving the hyperglycemia of a diabetes model rat.
Description
Technical Field
The invention relates to the technical field of nutritional food processing, in particular to multifunctional konjac flour and a preparation method thereof.
Background
The konjak has higher nutritional and medical values, and modern researches show that the main chemical components of the konjak tuber are as follows: glucomannan, starch, other polysaccharides, crude protein, essential amino acids, potassium, calcium, magnesium, sodium, iron, manganese, copper and other trace elements necessary for human body.
Glucomannan in konjak is a relatively rich renewable natural polymer resource after starch and cellulose, has biodegradability and water solubility, is a dietary fiber with relatively high natural molecular weight and highest viscosity, can adsorb water molecules 200 times of the volume of the glucomannan to form a viscous solution, can enhance satiety, and cannot generate heat because the glucomannan is not influenced by digestive enzymes of a human body. Is a recognized soluble multifunctional polysaccharide, and can generate konjak oligosaccharide with stronger function after being degraded moderately. However, the water-absorbing swelling and dissolution rate is very slow, usually 2 hours or more.
The degradation method of konjak fine powder (glucomannan) includes mechanical degradation method, radiation degradation method, ultrasonic degradation method, acidolysis method, oxidative degradation method, enzymolysis method and composite application of several methods. The enzymatic degradation has the advantages of high efficiency, specificity, mild condition, purer product, easily controlled degradation degree, no environmental pollution and the like, and the prior art mostly adopts single enzyme technology, and has the phenomena of low enzymolysis degree, low utilization rate of raw material fine powder and the like.
Disclosure of Invention
The invention aims to provide a multifunctional konjac flour simultaneously containing instant konjac glucomannan and konjac oligosaccharide and a preparation method thereof, which overcome the defects of excessive degradation or insufficient degradation in the prior art, have high flour yield and low water content, and simultaneously have the functions of the konjac glucomannan and the konjac oligosaccharide.
In order to achieve the above object, the present invention provides the following technical solutions:
the invention provides a preparation method of multifunctional konjac flour, which comprises the following steps:
(1) mixing rhizoma Amorphophalli refined powder, enzyme and water, and performing enzymolysis to obtain zymolyte;
(2) carrying out solid-liquid separation on the zymolyte to obtain a liquid part;
(3) and drying the obtained liquid part to obtain the multifunctional konjac flour.
Preferably, the enzyme in step (1) comprises glucomannanase, cellulase and pectinase.
Preferably, the dosage of the glucomannanase is 50-70 u/g of konjac refined powder, the dosage of the cellulase is 40-60 u/g of konjac refined powder, and the pectinase accounts for 0.03-0.05% of the total mass of the system.
Preferably, the ratio of the konjac powder to the water in the step (1) is 15-23 g:100 ml.
Preferably, the enzymolysis temperature in the step (1) is 55-65 ℃, and the enzymolysis time is 2-3 h.
Preferably, the solid-liquid separation in the step (2) includes centrifugal separation and suction filtration performed sequentially.
Preferably, the factor of the centrifugal separation is 2000-3000 g.
Preferably, the drying in step (3) is spray drying.
Preferably, the dry feeding flow is 8-18 r/min, the air inlet temperature is 150-220 ℃, and the air inlet flow is 30-60 Hz.
The invention also provides the multifunctional konjac flour prepared by the preparation method.
The invention provides a multifunctional konjak powder which has the effects of preventing obesity, reducing blood fat and preventing hepatic steatosis; has effects in reducing blood glucose, reducing lipid peroxidation, relieving inflammation, and improving organism free radical scavenging, and can be used for improving hyperglycemia of diabetes model rat.
The invention also provides a preparation method of the multifunctional konjac flour, wherein the flour yield is 12.5%, and the water content is 3.23%. Color was measured by a colorimeter, and the color was found to be easily soluble in water with a value of L of 85.17, a of-0.96 and b of 4.33. The main components are konjac oligosaccharide and soluble polysaccharide. The product is produced without any processing aids (including acids and bases) and food additives (including preservatives, thickeners, flavors, colors, etc.) other than food grade enzyme preparations. The product can be directly eaten as health food, and can also be used as a multifunctional (health) food additive for other foods and beverages.
Detailed Description
The invention provides a preparation method of multifunctional konjac flour, which comprises the following steps:
(1) mixing rhizoma Amorphophalli refined powder, enzyme and water, and performing enzymolysis to obtain zymolyte;
(2) carrying out solid-liquid separation on the zymolyte to obtain a liquid part;
(3) and drying the obtained liquid part to obtain the multifunctional konjac flour.
In the present invention, the konjac flour is preferably a commercially available konjac flour with high purity.
In the present invention, the enzyme in the step (1) preferably comprises glucomannanase, cellulase and pectinase.
In the invention, the dosage of the glucomannanase is preferably 50-70 u/g of konjac refined powder, more preferably 55-65 u/g of konjac refined powder, and even more preferably 60-62 u/g of konjac refined powder; the dosage of the cellulase is preferably 40-60 u/g of konjac refined powder, more preferably 45-55 u/g konjac refined powder, and still more preferably 47-52 u/g konjac refined powder; the dosage of the pectinase is preferably 0.03-0.05% of the total mass of the system, and more preferably 0.035-0.04% of the total mass of the system.
In the present invention, the system refers to a mixture obtained by mixing konjac powder, enzyme and water.
The invention preferably mixes the konjak fine powder and the enzyme firstly and then mixes the konjak fine powder and the enzyme with water.
In the present invention, the ratio of the konjac powder to water in the step (1) is preferably 15 to 23g to 100ml, and more preferably 18 to 20g to 100 ml.
In the invention, the enzymolysis temperature in the step (1) is preferably 55-65 ℃, and further preferably 58-60 ℃; the enzymolysis time is preferably 2-3 h.
The principle of the enzymolysis is as follows: according to the specificity of the enzyme, the glucomannan is simultaneously enzymolyzed into the konjac oligosaccharides by the glucomannan enzyme and the cellulase, the cellulase is enzymolyzed into the glucose by the cellulase, and the pectin is enzymolyzed into the galacturonic acid by the pectinase so as to destroy the structure of the konjac refined powder particles, thereby improving the action effect of other enzymes.
In the present invention, the solid-liquid separation in the step (2) preferably comprises centrifugal separation and suction filtration performed sequentially.
In the present invention, the factor of the centrifugal separation is preferably 2000 to 3000g, more preferably 2200 to 2800g, and still more preferably 2600 to 2800 g.
In the invention, the suction filtration is preferably carried out by using a filter cloth commonly used for yellow wine production.
In the present invention, the drying in the step (3) is preferably spray drying.
In the present invention, the spray drying is preferably carried out by a model RY-1500 spraying machine.
In the invention, the feeding flow rate of the drying is preferably 8-18 r/min, and more preferably 10-15 r/min; the air inlet temperature is preferably 150-220 ℃, and is further preferably 170-200 ℃; the air inlet flow is preferably 30-60 Hz, and more preferably 40-50 Hz.
The invention also provides the multifunctional konjac flour prepared by the preparation method.
The technical solutions provided by the present invention are described in detail below with reference to examples, but they should not be construed as limiting the scope of the present invention.
Example 1
Step 1: enzymolysis: mixing 15g of konjac refined powder with glucomannanase, cellulase and pectinase, wherein the dosage of the glucomannanase is 50u/g of the konjac refined powder, the dosage of the cellulase is 40u/g of the konjac refined powder, and the dosage of the pectinase accounts for 0.03 percent of the total mass of the system. Then mixing with 100ml water, performing enzymolysis, and performing enzymolysis at 55 deg.C for 2h to obtain zymolyte.
Step 2: solid-liquid separation: and (3) carrying out centrifugal separation on the zymolyte under the condition of 2600g, collecting supernatant, and carrying out suction filtration to obtain clear filtrate. The absorbance of the supernatant was 0.6734, the viscosity was 7 mPas, and the soluble solids were 5.0%.
And step 3: and (3) drying: and (3) carrying out spray drying on the obtained clear filtrate, wherein the feeding flow rate of the drying is 8r/min, the air inlet temperature is 150 ℃, and the air inlet flow rate is 30Hz, so as to obtain the multifunctional konjac flour. The powder yield was 12.5% and the water content was 3.23%.
Color was measured by a colorimeter, and the value of L was 85.17, the value of a was-0.96, and the value of b was 4.33. The functional components (oligosaccharide and other soluble polysaccharides) account for 40.1% of the total sugar content, the yield is 5.3%, and the enzymolysis utilization rate of the refined powder is 91.8%.
The konjak powder prepared by the invention is easy to dissolve in water, and the main components are konjak oligosaccharide and soluble polysaccharide.
Example 2
Step 1: enzymolysis: mixing 20g of konjac refined powder with glucomannanase, cellulase and pectinase, wherein the dosage of the glucomannanase is 60u/g of the konjac refined powder, the dosage of the cellulase is 50u/g of the konjac refined powder, and the dosage of the pectinase accounts for 0.04 percent of the total mass of the system. Then mixing with 100ml water, performing enzymolysis, and performing enzymolysis at 60 deg.C for 2.5h to obtain zymolyte.
Step 2: solid-liquid separation: and (3) carrying out centrifugal separation on the zymolyte under the condition of 2800g, collecting supernatant, and carrying out suction filtration to obtain clear filtrate. The absorbance of the supernatant was 0.6674, the viscosity was 6 mPas, and the soluble solids were 5.0%.
And step 3: and (3) drying: and (3) carrying out spray drying on the obtained clear filtrate, wherein the feeding flow rate of the drying is 10r/min, the air inlet temperature is 200 ℃, and the air inlet flow rate is 50Hz, so as to obtain the multifunctional konjac flour. The powder yield was 12.2% and the water content was 3.18%.
Color was measured by a colorimeter and had a value of L of 84.98, a of-0.93 and b of 4.28. The functional components (oligosaccharide and other soluble polysaccharides) account for 40.5% of the total sugar content, the yield is 5.9%, and the enzymolysis utilization rate of the refined powder is 92.6%.
The konjak powder prepared by the invention is easy to dissolve in water, and the main components are konjak oligosaccharide and soluble polysaccharide.
Example 3
Step 1: enzymolysis: mixing 23g of konjac refined powder with glucomannanase, cellulase and pectinase, wherein the dosage of the glucomannanase is 70u/g of the konjac refined powder, the dosage of the cellulase is 60u/g of the konjac refined powder, and the dosage of the pectinase accounts for 0.05 percent of the total mass of the system. Then mixing with 100ml water, performing enzymolysis, and performing enzymolysis at 65 deg.C for 3 hr to obtain zymolyte.
Step 2: solid-liquid separation: and (3) carrying out centrifugal separation on the zymolyte under the condition of 2900g, collecting supernatant, and carrying out suction filtration to obtain clear filtrate. The absorbance of the supernatant was 0.6712, the viscosity was 7 mPas, and the soluble solids were 5.0%.
And step 3: and (3) drying: and (3) carrying out spray drying on the obtained clear filtrate, wherein the feeding flow rate of the drying is 18r/min, the air inlet temperature is 220 ℃, and the air inlet flow rate is 60Hz, so as to obtain the multifunctional konjac flour. The powder yield was 12.4% and the water content was 3.21%.
Color was measured by color difference meter and the value of L was 85.06, a was-0.95 and b was 4.29. The functional components (oligosaccharide and other soluble polysaccharides) account for 39.8% of the total sugar content, the yield is 5.6%, and the enzymolysis utilization rate of the refined powder is 92.1%.
The konjak powder prepared by the invention is easy to dissolve in water, and the main components are konjak oligosaccharide and soluble polysaccharide.
Example 4
Animal experiments were conducted on the konjac powders prepared in examples 1 to 3.
Step 1: animal modeling and grouping
Selecting 50 healthy female mice, feeding common feed for 2 weeks, randomly dividing the healthy female mice into 2 groups, wherein one group is a blank control group of 10 mice (feeding common feed), the other group is a model control group of 40 mice (feeding high-fat feed), two groups are given unlimited feed, successfully establishing a mouse obesity model after feeding for 4 weeks, the model control group is arbitrarily divided into 4 groups, each group of 10 mice, and the 4 groups of mice are respectively a high-fat model group (feeding high-fat feed) and a konjac flour low-dose group (feeding high-fat feed and intragastric konjac flour of 15 mg.100 g)-1(BW)·d-1) And rhizoma Amorphophalli powder middle dose group (feeding high fat feed and intragastric administration of 30 mg-100 g rhizoma Amorphophalli powder)-1(BW)·d-1) And rhizoma Amorphophalli powder high dose group (feeding high fat feed and intragastric rhizoma Amorphophalli powder 60 mg-100 g)-1(BW)·d-1). And (3) continuously feeding the mice with the common feed in the blank control group, continuously feeding the high-fat feed to the mice in the high-fat model group and the low, medium and high dosage groups of the konjac flour, and continuously intragastrically feeding the konjac flour for one month. The breeding temperature is 24-27 ℃, the relative humidity is 45% -50%, and day and night intermittent illumination is adopted at a ratio of 11h to 13 h.
Step 2: sample collection
After feeding for 10 weeks, mice of each group are fasted for 12 hours, body mass is weighed before sacrifice, eyeballs are quickly picked and blood is taken after anesthesia, cervical vertebra dislocation is killed, fat around the liver, heart, spleen, kidney, lung and kidney and inguinal subcutaneous fat are quickly separated, organs are washed by saline, filter paper is sucked dry, and organs and tissues are weighed.
And step 3: index measurement
The growth state of the mice (the hair color, the food intake, the defecation and the activity of the mice) is recorded every day during the experiment, the daily food intake and the daily water intake of the mice are detected on the Wednesday and the Wednesday respectively, namely, the total feed amount and the total water addition amount are weighed on the Wednesday and the Wednesday, and the residual feed amount and the residual water amount are weighed on the Wednesday and the Friday at the same time. (i.e. total feed intake-residual feed intake, and total water intake-residual water intake). Body mass was weighed 1 time per saturday.
The abdomen was incised, and all fat in the body of the mouse, including adipose tissue around the kidney and subcutaneous adipose tissue of the groin, was removed and weighed, and the fat index was calculated according to equation (1).
Fat index/% ═ m1/m×100 (1)
In the formula: m is the mass of the mouse sacrifice precursor/g; m is1The mass of each adipose tissue per gram in the body of the mouse.
And 4, step 4: data processing
Statistical analysis was performed using SPSS 20 software, expressed as mean. + -. standard deviation, and single factor analysis of variance was used for comparisons between groups, with P < 0.05 indicating significant differences between groups.
TABLE 1 influence of konjaku flour on the change in body constitution/g (mean. + -. standard deviation) of mice
Note:*indicates a difference in P < 0.05 level compared to normal control, and # indicates a difference in P < 0.05 compared to the high lipid model group.
As can be seen from Table 1, significant differences (P < 0.05) exist between the high-fat model group and the normal control group and between the low-dosage, medium-dosage and high-dosage groups of the konjac flour, and the results show that each dosage of the konjac flour has a certain inhibition effect on the body mass of the mice.
Example 5
Animal experiments were conducted on the konjac powders prepared in examples 1 to 3.
Step 1: construction of diabetic rat model
60 healthy female rats are selected to be fed normally for 1 week, and the water intake and the food intake of experimental animals are measured periodically during the period. After 1 week, the body weight and fasting blood glucose values of the experimental animals were measured and recorded, and randomly grouped (normal control group and 5 building block group), 10 animals per group. The module-building rat induces diabetes by intraperitoneal injection of citric acid-sodium citrate buffer solution containing STZ (the STZ is dissolved by 1% of precooled citrate buffer solution pH 4.5, and is filtered and sterilized by a 0.22mol/L microporous filter membrane, the STZ is easy to inactivate, after being quickly weighed, the STZ is wrapped by tinfoil and protected from light and is used as it is and is placed in an ice bath for standby at any time), the concentration of the injected STZ is 45mg/kg and the injection amount is 2%, the intraperitoneal injection of the normal group of rats is performed with the citric acid-sodium citrate buffer solution with the same volume, and the intraperitoneal skin of the rats needs to be sterilized in the STZ injection process to prevent infection. After the injection was completed, the original diet was maintained in each group. After 24h, blood is collected from the tail of the rat, the fasting blood glucose value is measured, the fasting blood glucose of the rat is measured by using a glucometer and a matched blood glucose test paper, and when the fasting blood glucose of the rat of the model group is greater than 16.7mmol/L (the fasting blood glucose can be repeatedly measured for 2-3 times, the blood glucose is stable), and the symptoms of polydipsia, diuresis and weight loss appear, the model is considered to be successful.
Step 2: animal grouping and administration
The diabetic rats successfully molded are adjusted in groups, namely a high-dosage group, a medium-dosage group, a low-dosage group, a positive drug group and a diabetes model group of the konjac flour, and the normal group is set when the blood sugar value is consistent with that before molding. Gavage was continued for 6 weeks, during which time the rats in each group were normally free to drink water and ingest food. The gavage time is 4 pm daily, and the gavage administration dose of each group of rats is as follows: the gavage dose of the konjac flour in the high group, the gavage dose of the konjac flour in the middle group and the gavage dose of the konjac flour in the low group are respectively 2.500 g/(kg.d), 1.250 g/(kg.d) and 0.625 g/(kg.d), the administration dose of the positive drug group is 0.140 g/(kg.d), and the normal group and the high-sugar model group are fed with the same amount of physiological saline.
And step 3: index measurement
Measuring and recording the body weight of each group of rats every week during the gavage administration period of the rats, and analyzing and comparing the body weight difference of each group of rats, wherein the result is expressed in g; measuring the fasting blood sugar value of each group of experimental rats, expressing the result as mmol/L, analyzing and comparing the blood sugar level change of each group of rats; the water intake, feed intake of the experimental animals were measured and recorded, and the change in water intake and feed intake of the rats in each group during the gavage period was analyzed.
And 4, step 4: statistical method
Statistical analysis was performed using SPSS 20 software, expressed as mean. + -. standard deviation, and single factor analysis of variance was used for comparisons between groups, with P < 0.05 indicating significant differences between groups.
TABLE 2 influence of konjaku flour on fasting plasma glucose of diabetic rats
Note: the model group was compared to the normal group,**p < 0.01, indicating that the difference is extremely significant; the treatment group was compared with the model group,#p < 0.05, indicating significant difference.
As can be seen from Table 2, before modeling, the blood sugar values of rats in each group have no significant difference, the blood sugar values of the rats in the model group have significant difference (P is less than 0.01) compared with those of the normal group when the model group is administered at 0d, the blood sugar values of the rats in the model group have significant difference (P is less than 0.01) compared with those of the normal group when the model group is administered at 42d, the blood sugar values of the rats in the model group have significant difference (P is less than 0.01) compared with those of the rats in the positive drug group and each dosage group of konjac flour have significant difference (P is less than 0.05), and the blood. Namely, the konjac flour has similar effect to that of the positive drug group metformin in reducing the fasting blood glucose of the diabetic rat, so that the konjac flour can reduce the fasting blood glucose of the diabetic rat to a certain extent.
According to the embodiment, the invention provides the preparation method of the multifunctional konjac flour, and animal (white mouse) experiments show that the product has the effects of preventing obesity, reducing blood fat and preventing liver steatosis; has effects in reducing blood glucose, reducing lipid peroxidation, relieving inflammation, and improving organism free radical scavenging, and can be used for improving hyperglycemia of diabetes model rat.
The foregoing is only a preferred embodiment of the present invention, and it should be noted that, for those skilled in the art, various modifications and decorations can be made without departing from the principle of the present invention, and these modifications and decorations should also be regarded as the protection scope of the present invention.
Claims (10)
1. The preparation method of the multifunctional konjac flour is characterized by comprising the following steps:
(1) mixing rhizoma Amorphophalli refined powder, enzyme and water, and performing enzymolysis to obtain zymolyte;
(2) carrying out solid-liquid separation on the zymolyte to obtain a liquid part;
(3) and drying the obtained liquid part to obtain the multifunctional konjac flour.
2. The method of claim 1, wherein the enzyme of step (1) comprises a glucomannanase, a cellulase and a pectinase.
3. The method according to claim 2, wherein the glucomannanase is used in an amount of 50 to 70u/g of the konjac powder, the cellulase is used in an amount of 40 to 60u/g of the konjac powder, and the pectinase is used in an amount of 0.03 to 0.05% of the total mass of the system.
4. The method according to claim 1, wherein the ratio of the konjac powder to the water in the step (1) is 15 to 23 g/100 ml.
5. The preparation method according to any one of claims 1 to 4, wherein the temperature of enzymolysis in the step (1) is 55 to 65 ℃, and the time of enzymolysis is 2 to 3 hours.
6. The production method according to claim 1, wherein the solid-liquid separation in the step (2) comprises centrifugal separation and suction filtration performed sequentially.
7. The method of claim 6, wherein the centrifugation factor is 2000 to 3000 g.
8. The method according to claim 1, wherein the drying in the step (3) is spray drying.
9. The preparation method of claim 1 or 8, wherein the dry feed flow rate is 8-18 r/min, the inlet air temperature is 150-220 ℃, and the inlet air flow rate is 30-60 Hz.
10. The multi-functional konjac flour obtained by the production method according to any one of claims 1 to 9.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010212555.8A CN111264813A (en) | 2020-03-24 | 2020-03-24 | Multifunctional konjac flour and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010212555.8A CN111264813A (en) | 2020-03-24 | 2020-03-24 | Multifunctional konjac flour and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111264813A true CN111264813A (en) | 2020-06-12 |
Family
ID=70991828
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010212555.8A Pending CN111264813A (en) | 2020-03-24 | 2020-03-24 | Multifunctional konjac flour and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111264813A (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1904059A (en) * | 2006-05-29 | 2007-01-31 | 湖北广华生物有限公司 | Production method of konjak mannose using cellulase |
CN103060399A (en) * | 2013-01-04 | 2013-04-24 | 西南大学 | Method for producing konjac glucomannan |
CN103652542A (en) * | 2012-09-10 | 2014-03-26 | 陈运忠 | Konjac dietary fiber food with high bioavailability and preparation method of konjac dietary fiber food |
JP2016034244A (en) * | 2014-08-01 | 2016-03-17 | 蒟蒻屋本舗株式会社 | Usage of konjak fluid material |
CN105876298A (en) * | 2014-11-07 | 2016-08-24 | 重庆市涪陵区渝杨榨菜(集团)有限公司 | Preparation method of glucomannan-neutralized oligosaccharide liquid by refined konjak powder |
CN108185294A (en) * | 2016-12-08 | 2018-06-22 | 陕西理工大学 | A kind of black rice konjaku complex enzyme hydrolysis liquid and preparation method thereof |
-
2020
- 2020-03-24 CN CN202010212555.8A patent/CN111264813A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1904059A (en) * | 2006-05-29 | 2007-01-31 | 湖北广华生物有限公司 | Production method of konjak mannose using cellulase |
CN103652542A (en) * | 2012-09-10 | 2014-03-26 | 陈运忠 | Konjac dietary fiber food with high bioavailability and preparation method of konjac dietary fiber food |
CN103060399A (en) * | 2013-01-04 | 2013-04-24 | 西南大学 | Method for producing konjac glucomannan |
JP2016034244A (en) * | 2014-08-01 | 2016-03-17 | 蒟蒻屋本舗株式会社 | Usage of konjak fluid material |
CN105876298A (en) * | 2014-11-07 | 2016-08-24 | 重庆市涪陵区渝杨榨菜(集团)有限公司 | Preparation method of glucomannan-neutralized oligosaccharide liquid by refined konjak powder |
CN108185294A (en) * | 2016-12-08 | 2018-06-22 | 陕西理工大学 | A kind of black rice konjaku complex enzyme hydrolysis liquid and preparation method thereof |
Non-Patent Citations (3)
Title |
---|
党娅等: "魔芋低聚糖生产制备工艺优化研究", 《食品工业科技》 * |
吴长菲等: "魔芋葡甘露低聚糖的酶法制备工艺的初步研究", 《生物技术通报》 * |
李庆国等: "魔芋葡甘低聚糖的制备和分析", 《湖北工学院学报》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107279236A (en) | A kind of low AGEs inulin cookies and preparation method thereof | |
WO2011047518A1 (en) | Enteral nutrition comprising marine bioactive polysaccharide, preparation method and use thereof | |
CN113647498A (en) | Synbiotic functional soft sweet containing sea cucumber oligopeptide and preparation method thereof | |
CN106666572A (en) | Pogostemon auricularius jelly and making method thereof | |
CN104877035A (en) | Preparation method of auricularia polysaccharide with hypoglycemic effect | |
CN104814439B (en) | A kind of egg white small peptide decompression nutrient powder and preparation method | |
CN111513273A (en) | Konjak functional food and preparation method thereof | |
JPS63269993A (en) | Partially decomposed product of hardly digestible polysaccharides, its production and food containing same | |
CN107455663A (en) | Polypeptide dietotherapy noodles of diabetic and preparation method thereof | |
CN107439936A (en) | Polypeptide Diatotherapeutic flour of diabetic and preparation method thereof | |
KR100448009B1 (en) | Method for producing functional jelly having herb extracts and itself thereby | |
CN107094840B (en) | Kiwi fruit biscuit and preparation method thereof | |
CN103251100B (en) | Maggot peptide beverage and production technology thereof | |
CN105146324A (en) | Special low-protein potato full flour noodle for patients with diabetic nephropathy and preparation method thereof | |
CN107495020A (en) | A kind of suitable polypeptide beverage water of diabetic population and its preparation technology | |
CN111518854A (en) | Multi-enzyme zymolyte of konjac fine powder and preparation method thereof | |
CN111264813A (en) | Multifunctional konjac flour and preparation method thereof | |
CN108617833A (en) | Jujube cotton candy and production method | |
CN1305382C (en) | Yam milk powder with blood sugar lowering function | |
CN110089618A (en) | A kind of soya-bean polypeptides of low sodium content and preparation method thereof | |
CN105385736A (en) | Preparation process for protein peptide of Tenebrio molitor | |
CN108378262A (en) | A kind of polysaccharide dietotherapy solid-state drink and preparation method thereof for toxin-expelling and face nourishing | |
KR102362147B1 (en) | Method for producing low calorie gummy jelly using Ainsliaea acerifolia extract powder | |
JP5672588B2 (en) | Diet composition | |
CN113455550B (en) | Momordica grosvenori bean curd and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200612 |